News
A SUCCESSFUL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS HAS BEEN DEVELOPED BY A COMPUTER
14.08.2020

The first-of-its-kind respiratory syncytial virus vaccine developed by artificial intelligence has shown good results.

AN INNOVATIVE PRODRUG FOR LIVER CANCER HAS RECEIVED AN ORPHAN DRUG STATUS
06.08.2020

The FDA has granted an orphan status to MIV-818 a new hepatocellular carcinoma drug manufactured by a small biotech company.

SCIENTISTS HAVE DEVELOPED A FUNDAMENTALLY NEW ANTIBIOTIC AGAINST TUBERCULOSIS
30.07.2020

According to scientists, the new drug is chemically aggressive and it is able to get inside the cells and destroy tuberculosis bacteria.

Scientists claim ultrasound can detect the likelihood of dementia
24.07.2020

Experts hope that the simple procedure will become standard for middle-aged people who are at risk of developing such disease.

Vitamin D deficiency increases risk of colorectal cancer
20.07.2020

Colorectal cancer is one of the most common cancer pathologies in both men and women. The risk of developing is 4.2% and 4.5% in women and men, respectively.

13% of cancer diseases are due to infections
05.06.2020

According to a recent global study by French scientists, infections are the reason for 13% of all new cancer diagnoses.

A universal flu vaccine is going to be tested in Oxford
19.05.2020

Researchers from Oxford University have initiated clinical trials of a flu vaccine that is potentially effective against all types of virus.

CHANGES IN GLIBOFIT® PACKAGING
30.04.2020

Can be recommended as an additional source of biologically active plant substances that promotes to carbohydrate metabolism and blood glucose normalization.

CHANGES IN HEPAKLIN®
30.04.2020

Can be recommended as a source of biologically active substances of plant origin. Helps normalization of liver function, bile passages.

NEW VACCINE AGAINST COVID-19 WILL BE ABLE TO SIMULATE CORONAVIRUS STRUCTURE
30.04.2020

The American company VBI Vaccines is developing a universal coronavirus vaccine that mimics the structure of the virus; earlier, using this technology, the company created a vaccine for hepatitis B.